JOURNAL OF COSMETIC SCIENCE 202 highest rate of change among all conditions studied. It may owe to the difference in life style—males possibly being more active in outdoor activity with less conscientious daily skin care. Nevertheless, these results of facial skin AGEs open up new research directions in skin aging and anti-glycation studies. CONCLUSION This study shows for the fi rst time the in vivo skin AGE data of the human facial skin as measured by autofl uorescence using a noninvasive technique. It adds new data to skin aging research. The low AGE level observed in the facial skin did not support the reported phenomenon that solar irradiation increases dermal glycation unless a signifi cant differ- ence in antioxidant activity is evident (34-36). The faster increase in AGE level in the facial skin of men may be due to their lack of adequate skin care when compared with women. Further study in the difference of antioxidant activity between genders may help elucidate the mechanisms of facial skin glycation and aging process. ACKNOWLEDGMENTS The authors would like to thank Gopa Majmudar, Charles Hu, Greg Hillebrand, Rong Kong, Robin Ray, and Yulia Park for their help in various aspects including concept discussion, reference collection, and clinical study organization. REFERENCES (1) R. Meerwaldt, R. Graaff, P. H. N. Oomen, T. P. Links, J. J. Jager, N. L. Alderson, S. R. Thorpe, J. W. Baynes, R. O. B. Gans, and A. J. Smit, Simple non-invasive assessment of advanced glycation endprod- uct accumulation, Diabetologia, 47, 1324–1330 (2004). (2) V. Vishwanath, K. E. Frank, C. A. Elmets, P. J. Dauchot, and V. M. Monnier, Glycation of skin col- lagen in type I diabetes mellitus correlation with long-term complications, Diabetes, 35, 916–921 (1986). (3) M. A. Smith, S. Taneda, P. L. Richey, S. Miyata, S. D. Yan, D. Stern, L. M. Sayre, V. M. Monnier, and G. Perry, Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc. Natl. Acad. Sci. USA, 91, 5710–5714 (1994). (4) A. Stitt, C. He, S. Friedman, L. Scher, P. Rossi, L. Ong, H. Founds, Y. M. Li, R. Bucala, and H. Vlassara, Elevated AGE modifi ed ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: Relationship to tissue AGEs, Mol. Med., 3, 617–627 (1997). (5) T. Miyata, Y. Wada, Z. Cai, Y. Iida, K. Horie, Y. Yasuda, K. Maeda, K. Kurokawa, and C. van Ypersele de Strihou, Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure, Kidney Int., 51, 1170–1181 (1997). (6) H. L. Lutgers , R. Graaff, T. P. Links, L. J. Ubink-Veltmaat, H. J. Bilo, R. O. Gans, and A. J. Smit, Skin autofl uorescence as a non-invasive marker of vascular damage in patients with type 2 diabetes mellitus, Diabetes Care, 29, 2654–2659 (2006). (7) H. L. Lutgers , E. G. Gerrits, R. Graaff, T. P. Links, W. J. Sluiter, R. O. Gans, H. J. Bilo, and A. J. Smit, Skin autofl uorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus, Diabetologia, 52, 789–797 (2009). (8) J. D. Maynard , M. Rohrscheib, J. F. Way, C. M. Nguyen, and M. N. Ediger, Noninvasive type 2 diabe- tes screening superior sensitivity to fasting plasma glucose and A1C, Diabetes Care, 30, 1120–1124 (2007). (9) M. N. Ediger, B. P. Olson, and J. D. Maynard. Noninvasive optical screening for diabetes, J. Diabetes Sci. Technol., 3, 776–780 (2009).

MEASUREMENT OF ADVANCED GLYCATION END-PRODUCTS 203 (10) M. J. Noordz ij, D. J. Mulder, P. H. Oomen, T. Brouwer, J. Jager, M. Castro Cabezas, J. D. Lefrandt, and A. J. Smit, Skin autofl uorescence and risk of micro- and macrovascular complications in patients with type 2 diabetes mellitus—A multi-centre study, Diabet. Med., 29, 1556–1561 (2012). (11) R. Meerwaldt , H. L. Lutgers, T. P. Links, R. Graaff, J. W. Baynes, R. O. Gans, and A. J. Smit, Skin autofl uorescence is a strong predictor of cardiac mortality in diabetes, Diabetes Care, 30, 107–112 (2007). (12) J. W. Hartog , A. P. de Vries, H. L. Lutgers, R. Meerwaldt, R. M. Huisman, W. J. van Son, P. E. de Jong, and A. J. Smit, Accumulation of advanced glycation end products, measured as skin autofl uorescence in renal disease, Ann. NY Acad. Sci., 1043, 299–307 (2005). (13) R. Meerwaldt , T. P. Links, R. Graaff, K. Hoogenberg, J. D. Lefrandt, J. W. Baynes, R. O. Gans, and A. J. Smit, Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy, Diabetologia, 48, 1637–1644 (2005). (14) N. J. McInty re, R. J. Fluck, C. W. McIntyre, and M. W. Taal, Skin autofl uorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3, Clin. J. Am. Soc. Nephrol., 6, 2356–2363 (2011). (15) A. Smit and E. Gerrits. Skin autofl uorescence as a measure of advanced glycation endproduct deposition: A novel risk marker in chronic kidney disease, Curr. Opin. Nephrol. Hypertens., 19, 527–533 (2010). (16) H. L. Nienhu is, K. de Leeuw, J. Bijzet, A. Smit, C. G. Schalkwijk, R. Graaff, C. G. Kallenberg, and M. Bijl, Skin autofl uorescence is increased in systemic lupus erythematosus but is not refl ected by elevated plasma levels of advanced glycation endproducts, Rheumatology, 47, 1554–1558 (2008). (17) Y. Ohnuki, R . Nagano, S. Takizawa, S. Takagi, and T. Miyata, Advanced glycation end products in patients with cerebral infarction, Intern. Med., 48, 587–591 (2009). (18) Y. Kouidrat, A. Amad, M. Arai, M. Miyashita, J. D. Lalau, G. Loas, and M. Itokawa, Advanced glyca- tion end products and schizophrenia: A systematic review, J. Psychiat. Res., 66, 112–117 (2015). (19) L. C. de Vos , M. J. Noordzij, D. J. Mulder, A. J. Smit, H. L. Lutgers, R. P. Dullaart, P. W. Kamphuisen, C. J. Zeebregts, and J. D. Lefrandt, Skin autofl uorescence as a measure of advanced glycation end prod- ucts deposition is elevated in peripheral artery disease, Arterioscler. Thromb. Vasc. Biol., 33, 131–138 (2013). (20) L. C. de Vos, D. J. Mulder, A. J. Smit, R. P. Dullaart, N. Kleefstra, W. M. Lijfering, P. W. Kamphuisen, C. J. Zeebregts, and J. D. Lefrandt, Skin autofl uorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease, Arterioscler. Thromb. Vasc. Biol., 34, 933–938 (2014). (21) S. Willemsen, J. W. Hartog, Y. M. Hummel, J. L. Posma, L. M. van Wijk, D. J. van Veldhuisen, and A. A. Voors, Effects of alagebrium, an advanced glycation endproduct breaker, in patients with chronic heart failure: Study design and baseline characteristics of the BENEFICIAL trial, Eur. J. Heart Fail., 12, 294–300 (2010). (22) M. Koetsier, H. L. Lutgers, C. de Jonge, T. P. Links, A. J. Smit, and R. Graaff, Reference values of skin autofl uorescence, Diabetes Technol. Ther., 12, 399–403 (2010). (23) K. Simon-Klenovics, R. Kollárová, J. Hodosy, P. Celec, and K. Sebeková, Reference values of skin auto- fl uorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population, Diabet. Med., 31, 581–585 (2014). (24) K. Nomoto, M. Yagi, S. Arita, U. Hamada, and Y. Yonei, A survey of fl uorescence derived from ad- vanced glycation end products in the skin of Japanese: Differences with age and measurement location, Anti-Aging Med., 9, 119–124 (2012). (25) X. Yue, H. Hu, M. Koetsier, R. Graaff, and C. Han, Reference values for the Chinese population of skin autofl uorescence as a marker of advanced glycation end products accumulated in tissue, Diabet. Med, 28, 818–823 (2013). (26) M. S. Ahmad, Z. A. Damanhouri, T. Kimhofer, H. H. Mosli, and E. Holmes, A new gender-specifi c model for skin autofl uorescence risk stratifi cation, Sci. Rep., 5, 10198 (2015). (27) R. Na, I. M. Stender, M. Henriksen, and H. C. Wulf, Autofl uorescence of human skin is age-related after correction for skin pigmentation and redness, J. Invest. Dermatol., 116, 536–540 (2001). (28) H. Masaki, Y. Okano, and H. Sakurai, Generation of active oxygen species from advanced glycation end-products (AGEs) during ultraviolet light A (UVA) irradiation and a possible mechanism for cell damaging, Biochem. Biophys. Acta, 1428, 45–56 (1999). (29) G. T. Wondrak, M. K. Jacobson, and E. L. Jacobson, Endogenous UVA-photosensitizers: Mediators of skin photodamage and novel targets for skin photoprotection, Photochem. Photobiol. Sci., 5, 215–237 (2005).